Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Fluoxetine for the treatment of childhood anxiety disorders.

Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, Bridge J, Heo J, Brent DA.

J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):415-23.

PMID:
12649628
[PubMed - indexed for MEDLINE]
2.

Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial.

Clark DB, Birmaher B, Axelson D, Monk K, Kalas C, Ehmann M, Bridge J, Wood DS, Muthen B, Brent D.

J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1263-70.

PMID:
16292118
[PubMed - indexed for MEDLINE]
3.

Fluoxetine for childhood anxiety disorders.

Birmaher B, Waterman GS, Ryan N, Cully M, Balach L, Ingram J, Brodsky M.

J Am Acad Child Adolesc Psychiatry. 1994 Sep;33(7):993-9.

PMID:
7961355
[PubMed - indexed for MEDLINE]
4.

Open fluoxetine treatment of mixed anxiety disorders in children and adolescents.

Fairbanks JM, Pine DS, Tancer NK, Dummit ES 3rd, Kentgen LM, Martin J, Asche BK, Klein RG.

J Child Adolesc Psychopharmacol. 1997 Spring;7(1):17-29.

PMID:
9192539
[PubMed - indexed for MEDLINE]
5.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
[PubMed - indexed for MEDLINE]
6.

SET-C versus fluoxetine in the treatment of childhood social phobia.

Beidel DC, Turner SM, Sallee FR, Ammerman RT, Crosby LA, Pathak S.

J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1622-32.

PMID:
18030084
[PubMed - indexed for MEDLINE]
7.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
[PubMed - indexed for MEDLINE]
8.

The treatment of childhood social anxiety disorder.

Beidel DC, Ferrell C, Alfano CA, Yeganeh R.

Psychiatr Clin North Am. 2001 Dec;24(4):831-46. Review.

PMID:
11723636
[PubMed - indexed for MEDLINE]
9.

Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.

Pollack MH, Simon NM, Zalta AK, Worthington JJ, Hoge EA, Mick E, Kinrys G, Oppenheimer J.

Biol Psychiatry. 2006 Feb 1;59(3):211-5. Epub 2005 Sep 1.

PMID:
16139813
[PubMed - indexed for MEDLINE]
10.

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.

Silverstone PH, Salinas E.

J Clin Psychiatry. 2001 Jul;62(7):523-9.

PMID:
11488362
[PubMed - indexed for MEDLINE]
11.

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9.

PMID:
11437015
[PubMed - indexed for MEDLINE]
12.

Comparison among clomipramine, fluoxetine, and placebo for the treatment of anxiety disorders in children and adolescents.

da Costa CZ, de Morais RM, Zanetta DM, Turkiewicz G, Lotufo Neto F, Morikawa M, Rodrigues CL, Labbadia EM, Asbahr FR.

J Child Adolesc Psychopharmacol. 2013 Dec;23(10):687-92. doi: 10.1089/cap.2012.0110.

PMID:
24350814
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
[PubMed - indexed for MEDLINE]
15.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
[PubMed - indexed for MEDLINE]
16.

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.

Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB.

J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1431-8.

PMID:
12447029
[PubMed - indexed for MEDLINE]
17.

Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.

Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G.

Am J Psychiatry. 2004 Oct;161(10):1864-71.

PMID:
15465984
[PubMed - indexed for MEDLINE]
18.

Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.

Walkup J, Labellarte M, Riddle MA, Pine DS, Greenhill L, Fairbanks J, Klein R, Davies M, Sweeney M, Abikoff H, Hack S, Klee B, Bergman RL, Lynn D, McCracken J, March J, Gammon P, Vitiello B, Ritz L, Roper M; Research Units on Pediatric Psychopharmacology Anxiety Study Group.

J Child Adolesc Psychopharmacol. 2002 Fall;12(3):175-88.

PMID:
12427292
[PubMed - indexed for MEDLINE]
19.

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.

Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD.

Am J Psychiatry. 1998 Nov;155(11):1570-7. Erratum in: Am J Psychiatry 1999 Jan;156(1):161.

PMID:
9812120
[PubMed - indexed for MEDLINE]
20.

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs. 2002;16(6):425-34. Review.

PMID:
12027788
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk